Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytokinetics, Incorporated - Common Stock
(NQ:
CYTK
)
76.94
-1.12 (-1.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytokinetics, Incorporated - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
10 Health Care Stocks Whale Activity In Today's Session
↗
January 04, 2024
Via
Benzinga
7 Stocks Primed for a Spectacular Comeback in 2024
↗
January 03, 2024
Although the usual suspects may carry confidence, these underappreciated comeback stocks might deliver the goods in 2024.
Via
InvestorPlace
2 Biotechs That Could Get Bought Out in 2024
↗
January 03, 2024
These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.
Via
The Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
↗
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study
↗
December 28, 2023
On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before.
Via
Investor's Business Daily
Cytokinetics Inc. (NASDAQ: CYTK) Leading the Way in Thursday Trading Based on Percentage Gain
December 21, 2023
Via
Investor Brand Network
Expert Ratings for Cytokinetics
↗
November 09, 2023
Via
Benzinga
Expert Ratings for Cytokinetics
↗
October 09, 2023
Via
Benzinga
Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch
↗
December 28, 2023
On Wednesday, Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy...
Via
Benzinga
Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday
↗
December 28, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher
↗
December 27, 2023
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...
Via
Benzinga
Topics
Stocks
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
↗
December 27, 2023
With Cytokinetics hitting a homerun with its heart failure drug, CYTK stock skyrocketed in part due to takeover interest.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
December 27, 2023
Via
Benzinga
Stocks Static As Post-Holiday Doldrums Hit
↗
December 27, 2023
Stocks are struggling for direction today, as the post-holiday doldrums take full effect.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 27, 2023
Via
Benzinga
Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December
↗
December 27, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...
Via
Benzinga
Topics
Economy
Stocks
Why Is Heart Disease Focused Cytokinetics Stock Trading Higher Today?
↗
December 27, 2023
Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten in patients with symptomatic obstructive
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 27, 2023
Via
Benzinga
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 14, 2023
Via
Benzinga
Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics
↗
November 01, 2023
Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one...
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know
↗
October 20, 2023
Via
Benzinga
Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
↗
October 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
October 10, 2023
Via
Benzinga
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
October 06, 2023
Gainers
Via
Benzinga
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
↗
October 06, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.
Via
Benzinga
Topics
Stocks
10 Health Care Stocks Whale Activity In Today's Session
↗
October 05, 2023
Via
Benzinga
The 3 Best Mid-Cap Stocks to Buy Now: September 2023
↗
September 07, 2023
With the best mid-cap stocks to buy, investors get the best of both worlds: an established business but with ample room to grow.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 05, 2023
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
